# ELUVIA™ Drug-eluting Stent Versus Zilver® PTX® Stent

Study · id `cardio:ct-nct02574481` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02574481](<https://clinicaltrials.gov/study/NCT02574481>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT02574481

Browse, organ or system: Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 524 participants.

## Technical summary

Registry record NCT02574481. Randomized; single masking; primary purpose treatment. Start 2015-12 (actual); primary completion 2017-12-28 (actual). Results posted on 2019-01-07.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 524 participants (enrolled count; ClinicalTrials.gov record NCT02574481, source copy `cardio:ctgov-nct02574481-2023-05-08`, retrieved 2026-10-31)
- Started: 2015-12 (actual) (ClinicalTrials.gov record NCT02574481, source copy `cardio:ctgov-nct02574481-2023-05-08`, retrieved 2026-10-31)
- Primary completion: 2017-12-28 (actual) (ClinicalTrials.gov record NCT02574481, source copy `cardio:ctgov-nct02574481-2023-05-08`, retrieved 2026-10-31)
- Completion: 2022-04-12 (actual) (ClinicalTrials.gov record NCT02574481, source copy `cardio:ctgov-nct02574481-2023-05-08`, retrieved 2026-10-31)
- Results first posted: 2019-01-07 (ClinicalTrials.gov record NCT02574481, source copy `cardio:ctgov-nct02574481-2023-05-08`, retrieved 2026-10-31)
- Countries: United States; Austria; Belgium; Canada; Germany; Japan; New Zealand (ClinicalTrials.gov record NCT02574481, source copy `cardio:ctgov-nct02574481-2023-05-08`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02574481-2023-05-08`, retrieved 2026-10-31)

## The registry's words

- Brief title: ELUVIA™ Drug-eluting Stent Versus Zilver® PTX® Stent
- Acronym: IMPERIAL
- Condition: Atherosclerosis of Native Arteries of the Extremities
- Intervention (Device): ELUVIA (Stent Implantation)
- Intervention (Device): Zilver PTX (Stent Implantation)
- Lead sponsor: Boston Scientific Corporation
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Atherosclerosis (`cardio:atherosclerosis`)
- Registry lists this organization as the lead sponsor: Boston Scientific (`cardio:boston-scientific`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: A polymer-coated, paclitaxel-eluting stent (Eluvia) versus a polymer-free, paclitaxel-coated stent (Zilver PTX) for endovascular femoropopliteal intervention (IMPERIAL): a randomised, non-inferiority trial (`cardio:pubmed-30262332`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Japanese Patients Treated in the IMPERIAL Randomized Trial Comparing Eluvia and Zilver PTX Stents (`cardio:pubmed-31690980`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Two-Year Efficacy and Safety Results from the IMPERIAL Randomized Study of the Eluvia Polymer-Coated Drug-Eluting Stent and the Zilver PTX Polymer-free Drug-Coated Stent (`cardio:pubmed-33225377`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: 24-Month Efficacy and Safety Results from Japanese Patients in the IMPERIAL Randomized Study of the Eluvia Drug-Eluting Stent and the Zilver PTX Drug-Coated Stent (`cardio:pubmed-34235560`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: b496d501f00d7b879df8f56856933f1a1af4d433eb0e1756ef741ff6ce05397b
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
